Prevalence of Epstein–Barr virus, Human Papillomavirus and Porphyromonas Gingivalis in Oral Cancer
Novelty in Biomedicine,
Vol. 9 No. 2 (2021),
10 June 2021
,
Page 46-51
https://doi.org/10.22037/nbm.v9i2.32773
Abstract
Background: Multiple risk factors are supposed to progress oral cavity carcinoma and among them, the role of
neither bacterial nor viral infections should be underestimated. Despite relentless efforts, the accelerating effects
of human papillomavirus (HPV), Epstein–Barr virus (EBV), and Porphyromonas gingivalis (P. gingivalis) on
oral cancer has not yet been recognized successfully. Taking advantage of these facts, in this study we evaluated
the prevalence of HPV, EBV, and P. gingivalis in oral cavity carcinoma.
Materials and Methods: A total of 43 oral cavity cancerous tissues and 29 healthy oral ones were collected from
Loghman Hospital, Tehran, Iran, between 2016 and 2018. After DNA extraction, the prevalence of HPV, EBV,
and P. gingivalis was evaluated by PCR.
Results: There were 53.5 well-differentiated (15 male, 9 female), 41.8% moderate (10 male, 5 female), and
4.7% poor (1 male, 3 female) adenocarcinoma paraffin-embedded tissue samples. PCR analysis has shown
that there were 1 HPV (age: 46; moderate adenocarcinoma) and 1 EBV (age: 62; moderate adenocarcinoma)
positive in different samples. No P. gingivalis was found and there was not any infected tissue with both EBV
and HPV. In 31% of control tissues, blisters were observed and in 51.7% there was no mucus. We did not find
any association between age, sex, and HPV, EBV positive samples.
Conclusion: As sample size can affect the results of epidemiological and clinical study, and due to the low
number of positive samples in this study, we concluded that HPV, EBV, and P. gingivalis may not have a
detrimental effect on the progression of oral cancer, but further studies are needed.
- EBV, HPV, P. gingivalis, Oral cancer
How to Cite
References
Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67(1):51-64.
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012;13(8):790-801.
Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S83-9.
Wang C, Liu XQ, Hou JS, Wang JN, Huang HZ. Molecular Mechanisms of Chemoresistance in Oral Cancer. Chin J Dent Res. 2016;19(1):25-33.
S Tavakolian, H Goudarzi, E Faghihloo. E-cadherin, Snail, ZEB-1, DNMT1, DNMT3A and DNMT3B expression in normal and breast cancer tissues. Aca Biochimica Polonica. 66(4):409-14.
Tavakolian S, Goudarzi H, Faghihloo E. Evaluating the expression level of miR-9-5p and miR-192-5p in gastrointestinal cancer: introducing novel screening biomarkers for patients. BMC Res Notes. 2020;13(1):226.
Radoï L, Paget-Bailly S, Cyr D, Papadopoulos A, Guida F, Tarnaud C, et al. Body mass index, body mass change, and risk of oral cavity cancer: results of a large population-based case-control study, the ICARE study. Cancer Causes Control. 2013;24(7):1437-48.
Radoï L, Paget-Bailly S, Guida F, Cyr D, Menvielle G, Schmaus A, et al. Family history of cancer, personal history of medical conditions and risk of oral cavity cancer in France: the ICARE study. BMC Cancer. 2013; 13:560.
Garrote LF, Herrero R, Reyes RM, Vaccarella S, Anta JL, Ferbeye L, et al. Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer. 2001;85(1):46-54.
Radoï L, Paget-Bailly S, Menvielle G, Cyr D, Schmaus A, Carton M, et al. Tea and coffee consumption and risk of oral cavity cancer: results of a large population-based case-control study, the ICARE study. Cancer Epidemiol. 2013;37(3):284-9
Tavakolian S, Goudarzi H, Faghihloo E. Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers. Infect Agent Cancer. 2020;15:27.
Doorbar J, Foo C, Coleman N, Medcalf L, Hartley O, Prospero T, et al. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology. 1997;238(1):40-52.
Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 1991;67(3):547-56.
Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 1991;67(3):547-56.
Faghihloo E, Sadeghizadeh M, Shahmahmoodi S, Mokhtari-Azad T. Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression. Cancer Gene Ther. 2016 Nov 11.
Ptaszyńska-Sarosiek I, Dunaj J, Zajkowska A, Niemcunowicz-Janica A, Król M, Pancewicz S, et al. Post-mortem detection of six human herpesviruses (HSV-1, HSV-2, VZV, EBV, CMV, HHV-6) in trigeminal and facial nerve ganglia by PCR. PeerJ. 2019;6:e6095.
Theil D, Derfuss T, Strupp M, Gilden DH, Arbusow V, et al. Cranial nerve palsies: herpes simplex virus type 1 and varizella-zoster virus latency. Ann Neurol. 2002;51(2):273-4.
Rahman R, Poomsawat S, Juengsomjit R, Buajeeb W. Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma. BMC Oral Health. 2019;19(1):142.
Faghihloo E, Saremi MR, Mahabadi M, Akbari H, Saberfar E. Prevalence and characteristics of Epstein-Barr virus-associated gastric cancer in Iran. Arch Iran Med. 2014;17(11):767-70.
Nichols FC, Clark RB, Liu Y, Provatas AA, Dietz CJ, et al. Glycine Lipids of Porphyromonas gingivalis Are Agonists for Toll-Like Receptor 2. Infect Immun. 2020;88(4):e00877-19.
Tavakolian S, Goudarzi H, Eslami G, Dayyani F, Kazeminezhad B, Faghihloo E. Prevalence of human papilloma virus and Epstein–Barr virus in tumorous and adjacent tissues of colorectal cancer in Iran. Gene Reports. 2020(20) 100774, 2452-0144
Groome PA, O'Sullivan B, Irish JC, Rothwell DM, Schulze K, Warde PR, et al. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States. J Clin Oncol. 2003;21(3):496-505.
Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002;252:206– 24.
Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol. 2006;7:149– 56.
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889-99.
Siebers TJ, Merkx MA, Slootweg PJ, Melchers WJ, van Cleef P, de Wilde PC. No high-risk HPV detected in SCC of the oral tongue in the absolute absence of tobacco and alcohol--a case study of seven patients. Oral Maxillofac Surg. 2008;12(4):185-8.
Yang SW, Lee YS, Chen TA, Wu CJ, Tsai CN. Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation. Cancer Epidemiol. 2009;33(2):118‐22.
Tomo S, Biss SP, Crivelini MM, de Oliveira SHP, Biasoli ÉR, Tjioe KC, et al. High p16INK4a immunoexpression is not HPV dependent in oral leukoplakia. Arch Oral Biol. 2020;115:104738.
Janecka-Widła A, Mucha-Małecka A, Majchrzyk K, Halaszka K, Przewoźnik M, Słonina D, et al. Active HPV infection and its influence on survival in head and neck squamous-cell cancer. J Cancer Res Clin Oncol. 2020;146(7):1677-92.
Carpén T, Syrjänen S, Jouhi L, Randen-Brady R, Haglund C, Mäkitie A, et al. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact. Cancer Immunol Immunother. 2020;69(8):1615-26.
Gupta I, Nasrallah GK, Sharma A, Jabeen A, Smatti MK, Al-Thawadi HA, et al. Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar. Cancer Cell Int. 2020;20:107.
Kofler B, Laimer J, Bruckmoser E, Steinbichler TB, Runge A, Schartinger VH, et al. The Role of HPV and Non-HPV Sexually Transmitted Infections in Patients with Oropharyngeal Carcinoma: A Case Control Study. Cancers (Basel). 2020;12(5):1192.
Fanetti G, Alterio D, Marvaso G, Gandini S, Rojas DP, Gobitti C, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in HPV status era for oropharyngeal cancer. Oral Dis. 2020;26(7):1384-92.
Wilms T, Khan G, Coates PJ, Sgaramella N, Fåhraeus R, Hassani A, et al. No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue. PLoS One. 2017;12(9):e0184201.
Prathyusha M M, Kattappagari KK, Chowdary D, Shekar PC, Alivelu D, R. Reddy BV. A study on association of epstein barr virus in oral squamous cell carcinoma using polymerase chain reaction technique. J NTR Univ Health Sci. 2020; 8:233-7.
Broccolo F, Ciccarese G, Rossi A, Anselmi L, Drago F, Toniolo A. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in keratinizing versus non- keratinizing squamous cell carcinoma of the oropharynx. Infect Agent Cancer. 2018;13:32.
Acharya S, Ekalaksananan T, Vatanasapt P, Loyha K, Phusingha P, Promthet S, et al. Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case-control study. J Oral Pathol Med. 2015;44(4):252-7.
Polz-Gruszka D, Morshed K, Stec A, Polz-Dacewicz M. Prevalence of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in south-eastern Poland. Infect Agent Cancer. 2015;10:37.
Ha NH, Park DG, Woo BH, Kim DJ, Choi JI, Park BS, et al. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs. Cytokine. 2016;86:64-72.
Mao S, Park Y, Hasegawa Y, Tribble GD, James CE, Handfield M, et al. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell Microbiol. 2007;9(8):1997-2007.
Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci. 2011;3(4):209-15.
Ha NH, Woo BH, Kim DJ, Ha ES, Choi JI, Kim SJ, et al. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties. Tumour Biol. 2015;36(12):9947-60.
Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6(26):22613-23.
- Abstract Viewed: 264 times
- pdf Downloaded: 114 times